Evaluation of transient hyperglycemia in non-diabetic patients with febrile neutropenia

European Journal of Internal Medicine
Dilek Ersil SoysalSezin Hızar

Abstract

We aimed to examine the effect of transient hyperglycemia in non-diabetic patients with febrile neutropenia. A total of 86 patients with febrile neutropenia were evaluated between June 2006 and December 2009. After measuring random blood glucose level at admission, cases with stress hyperglycemia were included in the study. Stress hyperglycemia was defined as documented random blood glucose level of 140 mg/dl and above without known diabetes mellitus, impaired glucose tolerance and impaired fasting glucose. A Multinational Association for Supportive Care in Cancer (MASCC) scoring system was used for the prediction of low and high risk patients according to medical complications at the onset of the febrile episode. There were more patients with stress hyperglycemia than the patients with normoglycemia in the high risk group (p = 0.001). The growth of gram negative bacteria and fungi was higher in patients with stress hyperglycemia than with normoglycemia (p = 0.001). The patients receiving antifungal therapy had a higher rate of stress hyperglycemia than the patients without receiving antifungal therapy (p = 0.009). The patients with stress hyperglycemia had higher mortality rates than the patients with normoglycemia (p = 0.007)...Continue Reading

References

Feb 24, 2001·Critical Care Clinics·K C McCowenB R Bistrian
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Jan 30, 2004·Diabetes Care·Stephen ClementUNKNOWN American Diabetes Association Diabetes in Hospitals Writing Committee
Mar 3, 2004·Intensive Care Medicine·Paul E Marik, Murugan Raghavan
Sep 6, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A GlasmacherA Prentice
Oct 26, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Luciano de Souza VianaRoberto Carlos Duarte

❮ Previous
Next ❯

Citations

Sep 18, 2014·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Susan Storey, Diane Von Ah
Jun 21, 2016·Current Diabetes Reports·Conor J BestVictor R Lavis
Jun 2, 2018·European Journal of Clinical Investigation·Guray GuvercinErhan Tatar
Oct 20, 2018·Acta Clinica Belgica·Ivanka PerčićIvana Milošević
Aug 20, 2016·Oncology Nursing Forum·Susan Storey, Diane Von Ah

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.